Fiche publication
Date publication
avril 2021
Journal
European journal of neurology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr GUILLEMIN Francis
Tous les auteurs :
Mathey G, Ancel T, Garot T, Soudant M, Pittion-Vouyovitch S, Guillemin F, Debouverie M, Epstein J
Lien Pubmed
Résumé
Patients with secondary progressive multiple sclerosis (SP MS) and clinical and/or radiological activity could be the more likely to benefit from disease modifying treatments. To evaluate the proportions each year after progression onset, we studied patients with SP MS onset between 2002 and 2012 from a population-based multiple sclerosis registry in North-Eastern France.
Mots clés
1. Multiple Sclerosis, 2. Secondary progression, 3. Activity, 4. Magnetic Resonance Imaging, 5. Epidemiology
Référence
Eur J Neurol. 2021 Apr 10;: